11:54 AM EST - Akela Pharma Inc. : reported a net loss and comprehensive loss for the fourth quarter of $13.6 million U.S. or $0.63 U.S. per share, in comparison a loss of $8.9 million U.S. or $0.75 U.S. per share in the same quarter a year ago. Revenues for the fourth quarter decreased to $3.53 million U.S. from $4.71 million U.S. in the previous-year quarter. Akela Pharma Inc.
shares T.AKL are trading even at $0.15.
